[1]GUIU B,MINELLO A,COTTET V,et al.A 30-year,population-based study shows improved management and prognosis of hepatocellular carcinoma[J].Clin Gastroenterol Hepatol,2010,8(11):986-991.
|
[2]NORDENSTEDT H,WHITE DL,EL-SERAG HB.The changing pattern of epidemiology in hepatocellular carcinoma[J].Dig Liver Dis,2010,42(Suppl 3):s206-s214.
|
[3] JEMALA,BRAFY,CENTER MM,et al.Global cancer statistics[J].CA Cancer J Clin,2011,61(2):69-90.
|
[4]CHEN WQ,ZHENG RS,ZENG HM,et al.Report of cancer incidence and mortality in China,2011[J].China Cancer,2015,24(1):1-10.(in Chinese)陈万青,郑荣寿,曾红梅,等.2011年中国恶性肿瘤发病和死亡分析[J].中国肿瘤,2015,24(1):1-10.
|
[5] FERLAY J,SHIN HR,BRAY F,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].Int J Cancer,2010,127(12):2893-2917.
|
[6]BOSCH FX,RIBES J,DAZ M,et al.Primary liver cancer:worldwide incidence and trends[J].Gastroenterology,2004,127(5 Suppl 1):s5-s16.
|
[7]Ministry of Health of the People's Republic of China.Diagnosis,management,and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝胆病杂志,2011,27(11):1141-1159.
|
[8] SHARIFF MI,COX IJ,GOMAA AI,et al.Hepatocellular carcinoma:current trends in worldwide epidemiology,risk factors,diagnosis and therapeutics[J].Expert Rev Gastroenterol Hepotol,2009,3(4):353-367.
|
[9]KENG VW,LARGAESPADA DA,VILLANUEVA A.Why men are at higher risk for hepatocellular carcinoma?[J].J Hepatol,2012,57(2):453-454.
|
[10] KIM SS,HWANG JC,LIM SG,et al.Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients:comparison between compensated and decompensated cirrhosis[J].Am J Gastroenterol,2014,109(8):1223-1233.
|
[11]CENI E,MELLO T,GALLI A.Pathogenesis of alcoholic liver disease:role of oxidative metabolism[J].World J Gastroenterol,2014,20(47):17756-17772.
|
[12] MERCER KE,HENNINGS L,RONIS MJ.Alcohol consumption,Wnt/β-catenin signaling,and hepatocarcinogenesis[J].Adv Exp Med Biol,2015,815:185-195.
|
[13] LI D,TANG H,HASSAN MM,et al.Diabetes and risk of pancreatic cancer:a pooled analysis of three large case-control studies[J].Cancer Causes Control,2011,22(2):189-197.
|
[14]XU CX,ZHU HH,ZHU YM.Diabetes and cancer:associations,mechanisms,and implications for medical practice[J].World J Diabetes,2014,5(3):372-380.
|
[15] HEMMINKI K,LI X,SUNDQIST J,et al.Risk of cancer following hospitalization for type 2 diabetes[J].Oncologist,2010,15(6):548-555.
|
[16]JI SW,WANG JB.The risk analysis of type 2 diabetes mellitus to the development of primary liver carcinoma[J].Chin Hepatol,2007,12(3):168-170.(in Chinese)季尚玮,王江滨.2型糖尿病对原发性肝癌发病的危险性分析[J].肝脏,2007,12(3):168-170.
|
[17] BROOKES MJ,COOPER BT.Hypertension and fatty liver:guilty by association?[J].J Hum Hypertens,2007,21(4):264-270.
|
[18]TURATI F,EDEFONTI V,TALAMINI R,et al.Family history of liver cancer and hepatocellular carcinoma[J].Hepatology,2012,55(5):1416-1425.
|
[19]VINCIGUERRA M,VEYRAT-DUREBEX C,MOUKIL MA,et al.PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-kappa Bp65/m TOR-dependent mechanism[J].Gastroenterology,2008,134(1):268-280.
|
[20] CHEN CJ,YANG HI,SU J,et al.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[J].JAMA,2006,295(1):65-73.
|
[21]PAPATHEORIDIS GV,CHAN HL,HANSEN BE,et al.Risk of hepatocellular carcinoma in chronic hepatitis B:assessment and modification with current antiviral therapy[J].J Hepatol,2015,62(4):956-967.
|
[22]TESTINO G,LEONE S,BORRO P.Alcohol and hepatocellular carcinoma:a review and a point of view[J].World J Gastroenterol,2014,20(43):15943-15954.
|
[23]ZHANG F,SHAO YF,XU Y,et al.The relationship between HBV replicative markers and hepatocarcinogenesis[J].Chin J Gen Surg,2006,21(1):1-3.(in Chinese)张峰,邵永孚,许杨,等.乙肝病毒活跃复制与肝细胞癌发生的相关性研究[J].中华普通外科杂志,2006,21(1):1-3.
|
[24]EL-SERAG HB,RUDOLPH KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology,2007,132(7):2557-2576.
|
[25]DUAN WB,WANG QW,ZHANG B,et al.Clinical analysis of 92cases of hepatic cholangiocarcinoma and 384 cases of hepatocellular carcinoma[J].China J Modern Med,2009,19(24):3786-3789.(in Chinese)段文斌,王群伟,张斌,等.胆管细胞性肝癌临床归属之我见(附92例胆管细胞性肝癌与384例肝细胞性肝癌的临床分析)[J].中国现代医学杂志,2009,19(24):3786-3789.
|
[26]DONG ZY,ZENG Q,WANG J,et al.Effect of primary tumor location on postoperative recurrence for patients with hepatocellular carcinoma[J].Cancer Res Prevent Treat,2012,39(5):542-546.(in Chinese)董忠谊,曾钦,王剑,等.肝癌首发部位对患者术后复发的影响[J].肿瘤防治研究,2012,39(5):542-546.
|